drugset / Trial / NCT03459794

Ivermectin and Human Immunity

NCT03459794

Phase 0 Completed 12 enrolled University of Georgia
RandomizedParallel-groupTriple-blindBasic science

Summary

We hypothesize that ivermectin, a drug used to treat parasitic worm infections, interacts with the human innate immune system and that this contributes to its anti-parasitic effects. Participants will donate blood before and after being administered the normal human dose of the drug. We will compare the cell types present in the blood and the chemicals known to influence the human immune system before and after the drug is given, as well as measuring any changes in gene expression in white blood cells 4 and 24hrs after the drug is taken.

Timeline

Start
2018-02-12
Primary completion
2018-04-09
Completion
2018-11-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ivermectin Small molecule 150 ug/kg Oral

Indications

No indication recorded.